Zobrazeno 1 - 10
of 273
pro vyhledávání: ''
Publikováno v:
Int Arch Allergy Immunol
Introduction: Few studies assess biologicals such as, omalizumab, mepolizumab, benralizumab, and dupilumab in patients suffering from chronic rhinosinusitis with nasal polyposis (CRSwNP). The reported success rate in these studies differ, and it rema
Publikováno v:
Complementary Medicine Research
Vitamin D has been shown to be associated with reduced risk and severity of COVID-19 and exerts regulating effects on all hallmarks of cancer. The goal of this study was to analyze the vitamin D status of a cancer patient cohort from our clinic in th
Autor:
Kazutaka Sunami, Kazuyuki Suzuki, Kazuyuki Shimizu, Kenshi Suzuki, Akio Maki, Morio Matsumoto, Fumika Shimada
Publikováno v:
Acta Haematol
Introduction: Panobinostat, bortezomib, and dexamethasone combination therapy demonstrated progression-free survival (PFS) benefit over bortezomib and dexamethasone alone in the PANORAMA-1 study in relapsed/refractory multiple myeloma (MM). Here, we
Autor:
Savtaj S. Brar, Carol Jane Swallow, Charles Henry Lim, Hao-Wen Sim, Jennifer J. Knox, Bryan A. Chan, Akina Natori, James Brierley, Osvaldo Espin-Garcia, Rebecca Wong, Jolie Ringash, Eric Chen, Elena Elimova, Sara Hafezi-Bakhtiari, John Kim, Raymond Woo-Jun Jang, Di Maria Jiang, Geoffrey Liu, Patrik Rogalla, Gail Darling, Stephanie Moignard
Publikováno v:
Oncology. 99:49-56
Background: Trimodality therapy (TMT) with neoadjuvant chemoradiotherapy (nCRT) using concurrent carboplatin plus paclitaxel (CP) followed by surgery is the standard of care for locoregional esophageal or gastroesophageal junction (GEJ) cancers. Alte
Autor:
Teresa Alonso-Gordoa, Juan W. Valle, Carlos F. Lopez, José A. Díaz, Marta Benavent, Rocio Garcia-Carbonero, Felip Vilardell, Adelaida La Casta, Vicente Alonso, Ángel Segura, Angela Lamarca, J. Hernando, Javier Gallego, A Castaño, Mónica Marazuela, Juan Carlos Percovich, Enrique Grande, Marta Llanos, Jorge Barriuso, Manuel Cánovas, Jaume Capdevila, Eduardo Feliciangeli, Guillermo Crespo, Ana Montes, Alberto Carmona-Bayonas, Paula Jiménez-Fonseca, Ana Custodio, Maria Del Carmen Riesco
Publikováno v:
Neuroendocrinology
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Jimenez-fonseca, P, Carmona-bayonas, A, Lamarca, A, Barriuso, J, Castaño, A, Benavent, M, Alonso, V, Riesco, M D C, Alonso-gordoa, T, Custodio, A, Sanchez Canovas, M, Hernando, J, López, C, La Casta, A, Fernandez Montes, A, Marazuela, M, Crespo, G, Diaz, J A, Feliciangeli, E, Gallego, J, Llanos, M, Segura, A, Vilardell, F, Percovich, J C, Grande, E, Capdevila, J, Valle, J & Garcia-carbonero, R 2021, ' External validity of somatostatin analogues trials in advanced neuroendocrine neoplasms: the GETNE-TRASGU study ', Neuroendocrinology, vol. 0, 0 . https://doi.org/10.1159/000514808
r-FISABIO. Repositorio Institucional de Producción Científica
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Jimenez-fonseca, P, Carmona-bayonas, A, Lamarca, A, Barriuso, J, Castaño, A, Benavent, M, Alonso, V, Riesco, M D C, Alonso-gordoa, T, Custodio, A, Sanchez Canovas, M, Hernando, J, López, C, La Casta, A, Fernandez Montes, A, Marazuela, M, Crespo, G, Diaz, J A, Feliciangeli, E, Gallego, J, Llanos, M, Segura, A, Vilardell, F, Percovich, J C, Grande, E, Capdevila, J, Valle, J & Garcia-carbonero, R 2021, ' External validity of somatostatin analogues trials in advanced neuroendocrine neoplasms: the GETNE-TRASGU study ', Neuroendocrinology, vol. 0, 0 . https://doi.org/10.1159/000514808
r-FISABIO. Repositorio Institucional de Producción Científica
[Introduction] Somatostatin analogs (SSA) prolong progression-free survival (PFS) in patients with well-differentiated gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs). However, the eligibility criteria in randomized clinical trials (RCTs)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edbb6eaf613cfb0cd25a206b7cfb8252
http://hdl.handle.net/10261/305797
http://hdl.handle.net/10261/305797
Autor:
Yosuke Suehiro, Hiroshi Aikata, Masataka Tsuge, Shinsuke Uchikawa, Yumi Kosaka, Akira Hiramatsu, Michio Imamura, Eisuke Murakami, Yuwa Ando, Kei Morio, Yasutoshi Fujii, Takashi Nakahara, K. Yamaoka, Kazuaki Chayama, Tomokazu Kawaoka, Shoichi Takahashi
Publikováno v:
Oncology. 98:727-733
Objective: Functional hepatic reserve is important when considering sequential tyrosine kinase inhibitor (TKI) therapy for patients with advanced hepatocellular carcinoma (HCC). We assessed albumin-bilirubin (ALBI) score and Child-Pugh class as indic
Publikováno v:
Skin Pharmacology and Physiology. 33:237-243
Background: The use of antioxidants has become a common practice in the development of antiaging cosmetics. Objective: The aim of this study was to evaluate the clinical efficacy of cosmetic formulations containing lycopene and melatonin antioxidants
Autor:
Rosa Metella Refini, Elena Bargagli, Francesco Bianchi, Paolo Cameli, Laura Bergantini, Miriana d'Alessandro, Piersante Sestini
Publikováno v:
International Archives of Allergy and Immunology. 181:746-753
Background: New anti-IL-5 antibodies, mepolizumab and benralizumab, have recently been approved for severe asthma, sharing the same inclusion criteria. Objective: To contribute on biomarkers research leading to the personalized choice, we investigate
Autor:
Achim Rieth, H. Tilman Steinmetz, Wolfram Poenisch, Andrea Lebioda, Martina Schoehl, Moushmi Singh, Sebastian Gonzalez-McQuire
Publikováno v:
Oncol Res Treat
Introduction: Real-world data reflects treatments and outcomes in clinical practice in contrast with controlled clinical trials. This study evaluates real-life multiple myeloma (MM) patients receiving proteasome inhibitor (PI)-based treatments in the
Autor:
Mohammad Ali Sadiq, Syed Mahmood Shah, Zubir Rentiya, Quan Dong Nguyen, Bushra Usmani, Mustafa Iftikhar, Manneha A Qazi, Yasir J. Sepah, Saleema Kherani
Publikováno v:
Ophthalmologica. 243:27-36
Purpose: To evaluate the thickness of individual retinal layers in eyes with resolved diabetic macular edema (DME) after treatment with ranibizumab (RBZ). Methods: Spectral-domain optical coherence tomography (OCT) scans of 25 eyes (25 patients) with